- Investing Ideas
- /
- Japanese Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Japanese Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Results
6
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
6 companies
Santen Pharmaceutical
Market Cap: JP¥533.1b
Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.
4536
JP¥1,657.50
7D
5.5%
1Y
-1.1%
Hisamitsu Pharmaceutical
Market Cap: JP¥299.9b
Manufactures and sells pharmaceuticals in Japan.
4530
JP¥4,266.00
7D
1.2%
1Y
0.5%
Nippon Shinyaku
Market Cap: JP¥249.5b
Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.
4516
JP¥3,701.00
7D
2.2%
1Y
-13.4%
Kissei Pharmaceutical
Market Cap: JP¥190.7b
Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.
4547
JP¥4,600.00
7D
8.0%
1Y
26.7%
Mochida Pharmaceutical
Market Cap: JP¥122.8b
Manufactures and sells pharmaceuticals and healthcare products in Japan.
4534
JP¥3,465.00
7D
7.9%
1Y
5.0%
Kohjin Bio
Market Cap: JP¥7.9b
Manufactures and sells animal blood, sera, tissue culture media, agar media for microorganism tests, in-vitro diagnostic agents, and cosmetics.
177A
JP¥1,543.00
7D
-0.3%
1Y
-11.9%